Proactive Research Analyst John Savin speaks to Thomas Warner about his new research note on European based bio-pharma company MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC).
Savin gives a brief overview of MGC's operations in light of a recent placing, before giving his take on the company's current cash position.